Zobrazeno 1 - 10
of 27
pro vyhledávání: '"SELECTED ABSTRACTS - HMORN 2011: Cancer"'
Autor:
Mark C. Hornbrook, Paul A. Fishman, Maureen O’Keeffe-Rosetti, Debra P. Ritzwoller, Jennifer Elson Lafata
Background/Aims Estimates of the nation’s costs of cancer care are largely based on the SEER-Medicare datalink supplemented by modeling to estimate costs for non-aged patients. The SEER-Medicare data, however, are missing data on HMO (Medicare Adva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226c1d739ca0c3b0b8bc66eb02c087c1
https://europepmc.org/articles/PMC3251475/
https://europepmc.org/articles/PMC3251475/
Autor:
Steven B. Zeliadt, David C. Grossman, Diana S. M. Buist, Robert J. Reid, Ruth Etzioni, Shu Chen
Background/Aims A prostate specific antigen (PSA) level =4 ng/mL has historically been used as a screening threshold to recommend biopsy; however, guidelines have been changing to recommend lower cutoffs (2.5 ng/mL) and incorporate velocity in decisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3906a7d7c193562f8ec4d3527c64c5d7
https://europepmc.org/articles/PMC3251382/
https://europepmc.org/articles/PMC3251382/
Autor:
Carolyn D. Prouty, Doug Roblin, Cassandra L. Firneno, Brandi Robinson, Sarah M. Greene, Thomas H. Gallagher, Kathryn Horner, Kathleen M. Mazor
Background Adverse events and medical errors are challenging aspects of clinical care delivery, and also present challenges as topics for research. Nonetheless, understanding how and why such errors occur is critical to rendering improvements. Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b895f4ce7dfd8df1e1a1409a7557cf
https://europepmc.org/articles/PMC3251437/
https://europepmc.org/articles/PMC3251437/
Autor:
Sarah M. Greene, Terry S. Field, Joann L. Wagner, Brandi Robinson, Mary E. Costanza, Douglas W. Roblin, Mark Mooradian, Andrew R. Williams, Kathleen M. Mazor, Paul K. J. Han, Bridget Gaglio
Background Prostate cancer screening is controversial; treatment of early stage cancer has uncertain benefits, and complications are likely. Physician-patient discussions about PSA testing may be brief or absent. We investigated men’s familiarity a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec28beae1d640abb1856ecb1921b2b57
https://europepmc.org/articles/PMC3251426/
https://europepmc.org/articles/PMC3251426/
Background Patients with inherited mutations in one or both of the BRCA1/ BRCA2 genes are at substantially higher risk for developing breast cancer and other malignancies. Subsequent to testing becoming publicly available in the late 1990s, organizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8d16ad424cffde8abfcd18dcae9ea6
https://europepmc.org/articles/PMC3251355/
https://europepmc.org/articles/PMC3251355/
Autor:
Rebecca A. Silliman, Marianne Ulcickas Yood, Virginia P. Quinn, Jiaxiao Shi, Chantal Avila, Aruna Kamineni, Reina Haque
Background Almost 75% of breast cancer patients worldwide are treated with adjuvant therapy, primarily radiotherapy (RT). However, little is known about the long-term effects on cardiovascular health, particularly in older women.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3d03e685e85c932edb8942a58932d0
https://europepmc.org/articles/PMC3251357/
https://europepmc.org/articles/PMC3251357/
Background/Aims Tamoxifen is a widely prescribed endocrine therapy for prevention and treatment of breast cancer in pre- and post-menopausal women and is commonly recommended for five years duration. While most people tolerate tamoxifen reasonably we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8486dd2260769e01faffc5a751d6d952
https://europepmc.org/articles/PMC3251354/
https://europepmc.org/articles/PMC3251354/
Autor:
Andrew T. Sterrett, Tom Barney, Gabrielle Gundersen, Jessica M. Engel, Ted A. James, Kimberly Bischoff, Kathy Broecker, Heather Spencer Feigelson, Laurence E. McCahill, Erin J. Aiello Bowles, Adedayo A. Onitilo
Background/Aims Surgical quality is typically measured using 30-day morbidity and mortality statistics – measures that are not very meaningful for procedures such as lumpectomies and mastectomies that have extremely high survival rates. The Univers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7213ecdd10fc24381e70f85c6c4c053
https://europepmc.org/articles/PMC3251483/
https://europepmc.org/articles/PMC3251483/
Background/Aims Patient-centered communication (PCC) is a critical element of patient-centered care, which the Institute of Medicine (2001) promulgates as essential to improving healthcare delivery. The National Cancer Institute’s Strategic Plan fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6573f8fd68357918bb94e75884f47d89
https://europepmc.org/articles/PMC3251464/
https://europepmc.org/articles/PMC3251464/
Background/Aims Screening decreases colorectal cancer incidence and mortaility. However, almost half of eligible adults are not screened at recommended intervals. SOS: Systems of Support to Increase Colorectal Cancer Screening and Follow-up (R01CA121
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5834ac046e5ea5e72931deb11baad11
https://europepmc.org/articles/PMC3251404/
https://europepmc.org/articles/PMC3251404/